Michael Pollak
Michael Pollak
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Diabetes and cancer: a consensus report
E Giovannucci, DM Harlan, MC Archer, RM Bergenstal, SM Gapstur, ...
Diabetes care 33 (7), 1674-1685, 2010
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study
JM Chan, MJ Stampfer, E Giovannucci, PH Gann, J Ma, P Wilkinson, ...
Science 279 (5350), 563-566, 1998
Insulin and insulin-like growth factor signalling in neoplasia
M Pollak
Nature Reviews Cancer 8 (12), 915-928, 2008
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
SE Hankinson, WC Willett, GA Colditz, DJ Hunter, DS Michaud, B Deroo, ...
The Lancet 351 (9113), 1393-1396, 1998
Insulin-like growth factors and neoplasia
MN Pollak, ES Schernhammer, SE Hankinson
Nature Reviews Cancer 4 (7), 505-518, 2004
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
J Ma, MN Pollak, E Giovannucci, JM Chan, Y Tao, CH Hennekens, ...
Journal of the National Cancer Institute 91 (7), 620-625, 1999
Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial
JM Nabholtz, A Buzdar, M Pollak, W Harwin, G Burton, A Mangalik, ...
Journal of Clinical Oncology 18 (22), 3758-3767, 2000
Metformin is an AMP kinase–dependent growth inhibitor for breast cancer cells
M Zakikhani, R Dowling, IG Fantus, N Sonenberg, M Pollak
Cancer research 66 (21), 10269-10273, 2006
Metformin improves healthspan and lifespan in mice
A Martin-Montalvo, EM Mercken, SJ Mitchell, HH Palacios, PL Mote, ...
Nature communications 4 (1), 1-9, 2013
The insulin and insulin-like growth factor receptor family in neoplasia: an update
M Pollak
Nature Reviews Cancer 12 (3), 159-169, 2012
Metformin: from mechanisms of action to therapies
M Foretz, B Guigas, L Bertrand, M Pollak, B Viollet
Cell metabolism 20 (6), 953-966, 2014
Metformin inhibits mammalian target of rapamycin–dependent translation initiation in breast cancer cells
RJO Dowling, M Zakikhani, IG Fantus, M Pollak, N Sonenberg
Cancer research 67 (22), 10804-10812, 2007
Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)
Y Lu, X Zi, Y Zhao, D Mascarenhas, M Pollak
Journal of the National Cancer Institute 93 (24), 1852-1857, 2001
mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation
M Morita, SP Gravel, V Chénard, K Sikström, L Zheng, T Alain, V Gandin, ...
Cell metabolism 18 (5), 698-711, 2013
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy
O Kucuk, FH Sarkar, W Sakr, Z Djuric, MN Pollak, F Khachik, YW Li, ...
Cancer Epidemiology and Prevention Biomarkers 10 (8), 861-868, 2001
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
HR Bridges, AJY Jones, MN Pollak, J Hirst
Biochemical Journal 462 (3), 475-487, 2014
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
JR Mayers, C Wu, CB Clish, P Kraft, ME Torrence, BP Fiske, C Yuan, ...
Nature medicine 20 (10), 1193-1198, 2014
The type 1 insulin-like growth factor receptor pathway
MM Chitnis, JSP Yuen, AS Protheroe, M Pollak, VM Macaulay
Clinical cancer research 14 (20), 6364-6370, 2008
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
L Furic, L Rong, O Larsson, IH Koumakpayi, K Yoshida, A Brueschke, ...
Proceedings of the National Academy of Sciences 107 (32), 14134-14139, 2010
Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer
JM Chan, MJ Stampfer, J Ma, P Gann, JM Gaziano, M Pollak, ...
Journal of the National Cancer Institute 94 (14), 1099-1106, 2002
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20